Where are all the new Alzheimer’s drugs? Q&A with an expert

first_img Senior Writer, Science and Discovery (1956-2021) Sharon covered science and discovery. Privacy Policy Here’s a transcript of the conversation. [email protected] Newsletters Sign up for Daily Recap A roundup of STAT’s top stories of the day. @sxbegle Live ChatWhere are all the new Alzheimer’s drugs? Q&A with an expert Please enter a valid email address. By Sharon Begley and Damian Garde Sept. 18, 2017 Reprints Damian Gardecenter_img @damiangarde Why are there no good drugs to treat Alzheimer’s? More than 20 years after scientists discovered that mutations in three genes can cause the devastating disease, and that the apoE gene increases people’s risk for it, there are only four FDA-approved drugs to treat Alzheimer’s. And they do little but slow symptoms (if that).Over the last decade, more than 99 percent of the new compounds tested against Alzheimer’s have failed in clinical trials, costing their developers billions of dollars and crushing the hopes of the 5.5 million (and counting) Americans with the disease.Readers joined STAT reporters Sharon Begley and Damian Garde on Monday as they moderated a chat with Alzheimer’s expert Dr. Reisa Sperling of Brigham and Women’s Hospital. We aimed to cover a lot of ground: What drugs are in the pipeline, the therapeutic approaches, and which diet and lifestyle habits might prove protective. Sperling, who has relationships with several biopharma companies, also talked about her “A4 Study,” which is testing a new therapy in patients who are at high risk for Alzheimer’s, but as yet have no symptoms.advertisement Sharon Begley Leave this field empty if you’re human: About the Authors Reprints [email protected] Tags agingdementiadrug development National Biotech Reporter Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of “The Readout LOUD” podcast.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *